Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:36 PM
Study NCT ID:
NCT04656951
Status:
RECRUITING
Last Update Posted:
2022-04-05
First Post:
2020-11-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse
Sponsor:
University of Cologne
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2029-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-26
First Submit QC Date:
None
Study First Post Date:
2020-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-04
Last Update Post Date:
2022-04-05
Last Update Post Date Type:
ACTUAL